Toward a Generic Approach for Stress Testing of Drug Substances and Drug Products

The Impurity Profiling Group reviews stress testing according to regulatory guidance documents. The authors emphasize what should be considered for late clinical phases and for registration application dossiers.

Related Content:

AnalyticsFormulationManufacturingQuality SystemsGeneric DrugsDevelopmentPharmaceutical Technology-02-02-2005

With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs

Using Continuous Processes and Automation to Remove Contamination Risk

Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia